Interstitial Lung Disease

Gene: BMPR1B

Amber List (moderate evidence)

BMPR1B (bone morphogenetic protein receptor type 1B)
EnsemblGeneIds (GRCh38): ENSG00000138696
EnsemblGeneIds (GRCh37): ENSG00000138696
OMIM: 603248, Gene2Phenotype
BMPR1B is in 11 panels

1 review

Suzanna Lindsey-Temple (Liverpool Hospital)

I don't know

Gain-of-function variants.
PMID: 22374147. Only 2 reported cases. The first child was diagnosed at 6 years old with IPAH and he had no family history of PAH. He had a BMPR1B c.479 G>A p.S160N variant. No segregation was possible. The second child was diagnosed at 12 years of age with IPAH and no family history of PAH. She had a BMPR1B c.1176 C>A p.F392L variant which was also present in his unaffected father, but not mother, suggestive of low penetrance. Both mutations identified revealed experimental gain-of-function.
Created: 6 Nov 2021, 12:26 p.m. | Last Modified: 6 Nov 2021, 12:26 p.m.
Panel Version: 0.183

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Childhood pulmonary arterial hypertension.

Publications

Mode of pathogenicity
Other

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Amber
Phenotypes
  • Childhood pulmonary arterial hypertension
OMIM
603248
Clinvar variants
Variants in BMPR1B
Penetrance
None
Publications
Mode of Pathogenicity
Other
Panels with this gene

History Filter Activity

8 Nov 2021, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: bmpr1b has been classified as Amber List (Moderate Evidence).

8 Nov 2021, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: BMPR1B were changed from to Childhood pulmonary arterial hypertension

8 Nov 2021, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: BMPR1B were set to

8 Nov 2021, Gel status: 2

Set mode of pathogenicity

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of pathogenicity for gene: BMPR1B was changed from None to Other

8 Nov 2021, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: bmpr1b has been classified as Amber List (Moderate Evidence).

6 Nov 2021, Gel status: 0

Created, Added New Source, Set mode of inheritance

Suzanna Lindsey-Temple (Liverpool Hospital)

gene: BMPR1B was added gene: BMPR1B was added to Interstitial Lung Disease. Sources: Expert list Mode of inheritance for gene: BMPR1B was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted